Nestlé launches first baby milk in China

24 November 2023 14:19

Greater Geneva BernSwissCham Hong Kong

Vevey/Suzhou - Nestlé has launched a baby milk in China, which is at the same time its first product on this market to contain human milk oligosaccharides (HMOs). The National Health Commission in China recently approved the use of these human breast milk components in products.

Nestlé recently launched its first baby milk on the market in China, further details of which can be found in a press release. This has been made possible after China’s National Health Commission recently approved the use of human milk oligosaccharides (HMOs), which are the third most common solid component of human breast milk after lactose and lipids.

The baby milk is manufactured in the Nestlé factory in Suzhou and sold in China under the Wyeth illuma brand. In addition to HMOs, the product contains lipids and proteins and is claimed to benefit intestinal health, the immune system and cognitive development.

By launching this product, Nestlé is confirming its position as a key provider of HMO-based infant nutrition solutions in China, as the Swiss multinational food and drink processing conglomerate based in Vevey in the canton of Vaud explains in the press release. As the approval process progresses, Nestlé will continue to expand its HMO offering across China.

Isabelle Bureau-Franz, Head of Nestlé’s R&D for Nutrition, highlights the fact that Nestlé has been at “the forefront of understanding the composition of human breast milk” for more than 30 years. Nestlé was the first company in the world to launch products containing a complex of five HMOs on the market.

Just last month, Nestlé launched Sinergity in Hong Kong. This product combines a probiotic with six age-adapted HMOs from human milk. It will go on sale towards the end of this year in Latin America, before being rolled out early across Europe under the NAN Supremepro brand in early 2024. ce/mm

Swiss Pavilion Digital

Previous newsletters